Contact
Please use this form to send email to PR contact of this press release:
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
TO:
Please use this form to send email to PR contact of this press release:
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
TO: